P
PFE
PFEUnverified2 segments tracked|5 years of data|Annual (10-K)
Total Revenue
$62.4B6.7%
FY2024
Operating Segments
2Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Biopharma
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Biopharma | $62.4B | $0 | 0.0% | 100.0% | +9.1% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free